Saffron Walden, United Kingdom

Peter Alan Hunt

USPTO Granted Patents = 6 


Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Peter Alan Hunt

Introduction

Peter Alan Hunt, a talented inventor based in Saffron Walden, GB, is known for his significant contributions to the field of pharmaceuticals. With six patents to his name, his work primarily focuses on developing compounds that offer potential treatments for various neurological conditions.

Latest Patents

Hunt's recent innovations include two noteworthy patents. The first, titled "Diarylsulfones as 5-HT2A antagonists," describes compounds that act as potent and selective antagonists of the human 5-HT receptor. These compounds show promise in treating a range of adverse conditions affecting the central nervous system. The second patent involves "Substituted carbocyclic sulphonamide derivatives," which are also identified as selective 5-HT receptor antagonists. These derivatives are effective in treating ailments such as depression and sleep disorders, highlighting Hunt's commitment to advancing mental health treatments.

Career Highlights

Peter Alan Hunt has dedicated his career to research and development within the pharmaceutical industry. He currently works at Merck Sharp & Dohme Corporation, where he leverages his expertise to drive innovation in drug development. His work significantly contributes to understanding and addressing complex neurological challenges.

Collaborations

Throughout his career, Hunt has collaborated with esteemed colleagues, including Jose Luis Castro Pineiro and Angus Murray MacLeod. Their collective efforts have led to groundbreaking advancements in pharmacology, underscoring the importance of teamwork in the innovation process.

Conclusion

Peter Alan Hunt stands out as a prominent inventor in the pharmaceutical field, with a remarkable portfolio of patents aimed at improving mental health. His ongoing contributions at Merck Sharp & Dohme Corporation, coupled with fruitful collaborations, pave the way for future innovations that may change the landscape of neurological treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…